Related Experiment Video
Updated: Jun 12, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Emergent veno-arterial extra-corporeal membrane oxygenator support for refractory acute myocarditis in paediatric
Mimoza Maldi1, Guido M Olivieri2, Simone Ghiselli1
1Congenital Cardiac Surgery De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Insights
Severe heart failure in children due to acute myocarditis is rare but serious. Veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) is critical for survival in cardiogenic shock, and this study examines VA-ECMO outcomes.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Critical Care Medicine
Background:
- Acute myocarditis can cause severe heart failure in children.
- Refractory cardiogenic shock necessitates mechanical circulatory support.
- Veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) is a key intervention.
Purpose of the Study:
- To evaluate short- and long-term patient outcomes.
- To analyze the effectiveness of VA-ECMO in pediatric acute myocarditis.
- To provide data on survival and recovery post-VA-ECMO.
Main Methods:
- Retrospective analysis of pediatric patients with acute myocarditis.
- Inclusion of patients requiring VA-ECMO for cardiogenic shock.
- Assessment of in-hospital, short-term, and long-term outcomes.
Main Results:
- In-hospital mortality for VA-ECMO support is approximately 30%.
- VA-ECMO effectively restores perfusion in pediatric cardiogenic shock.
- Further analysis of short- and long-term outcomes is presented.
Conclusions:
- VA-ECMO is a vital treatment for pediatric acute myocarditis with refractory cardiogenic shock.
- Understanding VA-ECMO outcomes is crucial for patient management.
- This study contributes to the knowledge of VA-ECMO's role in pediatric critical care.
Abstract:
Acute myocarditis leading to severe heart failure in paediatric patients is an uncommon but potentially life-threatening condition. The prompt implant of mechanical circulatory devices such as veno-arterial extra-corporeal membrane oxygenation remains the best treatment option to restore an adequate perfusion and improve patient survival in case of refractory cardiogenic shock cases. While few reports describe the in-hospital course of this dramatic disease, with an in-hospital mortality under veno-arterial extra-corporeal membrane oxygenation support around 30%, our study aims to analyse both short- and long-term outcomes after extra-corporeal membrane oxygenation implant.
Related Concept Videos
Myocarditis III: Medical Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Cardiopulmonary Resuscitation IV: Pharmacological Management

